Samarth Kulkarni
Chief Executive Officer chez CRISPR THERAPEUTICS AG
Fortune : 28 M $ au 31/03/2024
Profil
Samarth Kulkarni est président de Casebia Therapeutics LLP. Le Dr Kulkarni siège également au conseil d'administration de Black Diamond Therapeutics, Inc, Repare Therapeutics, Inc et Centessa Pharmaceuticals Ltd. et est directeur général et administrateur de CRISPR Therapeutics AG et directeur de la section des sociétés émergentes de la Biotechnology Innovation Organization. Dans le passé, Samarth Kulkarni a occupé le poste d'associé chez McKinsey & Co, Inc. Il a obtenu un doctorat de l'université de Washington et un diplôme de premier cycle de l'Indian Institute of Technology New Delhi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG
0,48% | 15/04/2024 | 408 122 ( 0,48% ) | 28 M $ | 31/03/2024 |
| 22/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
| 16/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
REPARE THERAPEUTICS INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Samarth Kulkarni
| Sociétés | Poste | Début |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Executive Officer | 01/12/2017 |
| REPARE THERAPEUTICS INC. | Director/Board Member | 01/11/2019 |
| BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 01/12/2019 |
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 23/02/2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Chief Executive Officer | - |
Anciens postes connus de Samarth Kulkarni
| Sociétés | Poste | Fin |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/07/2015 |
Casebia Therapeutics LLP
 Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Chairman | - |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Director/Board Member | - |
Formation de Samarth Kulkarni
| University of Washington | Doctorate Degree |
| Indian Institute of Technology New Delhi | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Commercial Services |
